Addressing the Challenges of Artificial Intelligence used for Data Extraction in Systematic Literature Reviews
SLRs are an established method for synthesizing and evaluating evidence on a particular topic. They involve a systematic and transparent process for identifying, selecting, and extracting data from relevant studies, and for synthesizing and analyzing the data to draw conclusions about the topic being studied. Data extraction is a critical step in the SLR process, but it can be a time-consuming process that is open to error when done manually, particularly for large and complex reviews.
To address these challenges, researchers are increasingly turning to AI as a tool for data extraction in SLRs. This can significantly reduce the time and effort required for data extraction and can help to minimize errors and omissions, but it is only as good as the strategies, expertise, and perspectives applied by the researcher.
This whitepaper covers 5 key dimensions of AI use, including their challenges and solutions.
Related Insights
Webinar
Use of AI to develop health economic evidence for optimized patient access
Sep 6, 2023
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Blog
Regulatory acceptability of AI: Current perspectives
Mar 7, 2024
Video
Insights with Goldman Sachs Part 5: Pioneering new approaches, technologies, and AI to drive innovation
Jan 26, 2024
Article
Parexel principles for artificial intelligence (AI)
Mar 6, 2024
Playbook
Are you using real-world evidence?
Feb 1, 2023
Blog
Summary and assessment of EMA’s reflection paper on the use of artificial intelligence (AI) in the medicinal product lifecycle
Mar 7, 2024
Blog
Summary and assessment: Using Artificial Intelligence & Machine Learning in the Development of Drug & Biological Products: Discussion Paper and Request for Feedback (FDA)
Mar 7, 2024
Blog
AI Milestones: FDA’s ISTAND program accepts AI-based assessment tool for depression
Mar 19, 2024
Blog
AI Milestones: AI-enabled EKG reads and alerts save lives: human-AI collaboration in practice
Jun 6, 2024
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023
Related Insights
Webinar
Use of AI to develop health economic evidence for optimized patient access
Sep 6, 2023
Blog
Using ethical AI to streamline HEOR
Jan 26, 2024
Blog
Regulatory acceptability of AI: Current perspectives
Mar 7, 2024
Video
Insights with Goldman Sachs Part 5: Pioneering new approaches, technologies, and AI to drive innovation
Jan 26, 2024
Article
Parexel principles for artificial intelligence (AI)
Mar 6, 2024
Playbook
Are you using real-world evidence?
Feb 1, 2023
Blog
Summary and assessment of EMA’s reflection paper on the use of artificial intelligence (AI) in the medicinal product lifecycle
Mar 7, 2024
Blog
Summary and assessment: Using Artificial Intelligence & Machine Learning in the Development of Drug & Biological Products: Discussion Paper and Request for Feedback (FDA)
Mar 7, 2024
Blog
AI Milestones: FDA’s ISTAND program accepts AI-based assessment tool for depression
Mar 19, 2024
Blog
AI Milestones: AI-enabled EKG reads and alerts save lives: human-AI collaboration in practice
Jun 6, 2024
Article
How biotechs can strengthen their value story with advanced analytics
Feb 15, 2022
Blog
Generative AI and how we can harness its power in clinical development
Sep 26, 2023